SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

_ February 7, 2023____

Date of Report (date of earliest event reported)

BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware 001-37863 95-2645573
(State or Other Jurisdiction (Commission (IRS Employer

of Incorporation) File Number) Identification Number)

17571 Von Karman Ave.

# Irvine, California 92614

(Address of Principal Executive Offices

Including Zip Code)

949 - 645 - 2111

(Registrant’s Telephone Number,

Including Area Code)

______________

(Former Name or Former Address if Changed

Since Last Report)

Page 1 of 3 pages

Item 7.01 Regulation FD Disclosure

On February 6, 2023, Biomerica, Inc. (“the “Company”) presented an investor presentation to the investment community. The investor presentation is attached hereto as Exhibit 99.1.

The investor presentation is being furnished pursuant to General Instruction B.2 of Form 8-K and is not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor is it subject to the liabilities of that section or deemed incorporated by reference in any filing by the Company under the Exchange Act unless specifically identified therein as being incorporated therein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

Exhibit

Number Description

99.1 Investor Presentation

Page 2 of 3 pages

## SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 7, 2023 Biomerica, Inc.

By: /s/ Zackary S. Irani

Zackary S. Irani

Chief Executive Officer

Page 3 of 3 pages

false 0000073290 false false false false 0000073290 2023-02-07 2023-02-07